Skip to main content
SGMT
NASDAQ Life Sciences

Sagimet Posts 31c Quarterly Loss as Phase 3 R&D Spending Jumps 68%

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$11.4
Mkt Cap
$802.593M
52W Low
$4.5
52W High
$11.449
52W Position info
153% above low
Off High info
at 52W high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

SGMT has more than doubled off its 52-week low of $4.5.

Summary

Sagimet reported a third-quarter loss of 31 cents a share, with the net loss widening to $19.1M as R&D spending jumped 68% on the AURORA Phase 3 acne trial. The company ended the quarter with $275.8M in cash and securities, before the October offering added roughly $107.5M net. That cash position is the key number here: it funds the Phase 3 program well past the first patient dosing disclosed in the October investor presentation, so dilution risk near term is low. The wider loss is the expected cost of running the trial, not a surprise deterioration in the business. The stock is trading near its 52-week high, so the bar for these numbers was high.

At the time of this announcement, SGMT was trading at $11.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $802.6M. The 52-week trading range was $4.50 to $11.45. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

SGMT - Latest Insights

SGMT
Nov 12, 2026, 7:30 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.40
Real-time Price: $11.41 info
Change: +$0.0132 (+0.12%) info
Market Cap: $802.593M info
SGMT
Oct 01, 2026, 5:41 PM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $9.24
Real-time Price: $11.41 info
Change: +$2.17 (+24%) info
Market Cap: $802.593M info
SGMT
Sep 30, 2026, 6:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.03
Real-time Price: $11.41 info
Change: +$1.38 (+14%) info
Market Cap: $802.593M info
SGMT
Sep 30, 2026, 5:53 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $10.03
Real-time Price: $11.41 info
Change: +$1.38 (+14%) info
Market Cap: $802.593M info
SGMT
Sep 30, 2026, 6:19 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $9.99
Real-time Price: $11.41 info
Change: +$1.42 (+14%) info
Market Cap: $802.593M info